Improved negative-strand rna viral vector
AssigneeID Pharma Co., Ltd.
InventorKoichi SAEKI
Life of this patent
Estimating the term…
Loading patent…
AssigneeID Pharma Co., Ltd.
InventorKoichi SAEKI
Estimating the term…
The present invention addresses the problem of providing an improved negative-strand RNA viral vector enabling transient high expression of a gene carried by the vector, and quick removal of the vector after the expression, and the use thereof. It was found that if a degron is added to a P-protein possessed by a negative-strand RNA viral vector, high-level expression of a gene carried by the vector is transiently induced after introduction of the vector, and thereafter, the vector can be quickly removed in a manner dependent on the degron. In particular, if the degron is added to a temperature-sensitive P-protein, the vector can be removed to a level below the detection limit within two weeks after cells are infected with the vector. Since the present invention is useful for transiently expressing a transcription factor, such as a reprogramming factor or the like, in target cells, and then quickly removing the vector, the present invention is expected to be applied in cell therapy and regenerative medicine.
A negative-strand RNA virus vector, wherein the P gene of the vector has been modified so as to add a degron to the P protein of said virus.
7-10. (canceled)
Dependencies are inferred from the claim text.